Literature DB >> 17305471

Beta-arrestins and cell signaling.

Scott M DeWire1, Seungkirl Ahn, Robert J Lefkowitz, Sudha K Shenoy.   

Abstract

Upon their discovery, beta-arrestins 1 and 2 were named for their capacity to sterically hinder the G protein coupling of agonist-activated seven-transmembrane receptors, ultimately resulting in receptor desensitization. Surprisingly, recent evidence shows that beta-arrestins can also function to activate signaling cascades independently of G protein activation. By serving as multiprotein scaffolds, the beta-arrestins bring elements of specific signaling pathways into close proximity. beta-Arrestin regulation has been demonstrated for an ever-increasing number of signaling molecules, including the mitogen-activated protein kinases ERK, JNK, and p38 as well as Akt, PI3 kinase, and RhoA. In addition, investigators are discovering new roles for beta-arrestins in nuclear functions. Here, we review the signaling capacities of these versatile adapter molecules and discuss the possible implications for cellular processes such as chemotaxis and apoptosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17305471     DOI: 10.1146/annurev.physiol.69.022405.154749

Source DB:  PubMed          Journal:  Annu Rev Physiol        ISSN: 0066-4278            Impact factor:   19.318


  634 in total

Review 1.  Synthetic biology with surgical precision: targeted reengineering of signaling proteins.

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Cell Signal       Date:  2012-06-01       Impact factor: 4.315

Review 2.  Serotonin receptor signaling and regulation via β-arrestins.

Authors:  Laura M Bohn; Cullen L Schmid
Journal:  Crit Rev Biochem Mol Biol       Date:  2010-10-07       Impact factor: 8.250

3.  Serotonin, but not N-methyltryptamines, activates the serotonin 2A receptor via a ß-arrestin2/Src/Akt signaling complex in vivo.

Authors:  Cullen L Schmid; Laura M Bohn
Journal:  J Neurosci       Date:  2010-10-06       Impact factor: 6.167

4.  Signaling by sensory receptors.

Authors:  David Julius; Jeremy Nathans
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-01-01       Impact factor: 10.005

5.  β-Arrestin and dishevelled coordinate biased signaling.

Authors:  Gunnar Schulte; Sudha K Shenoy
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-28       Impact factor: 11.205

6.  Distinct Signaling Patterns of Allosteric Antagonism at the P2Y1 Receptor.

Authors:  Zhan-Guo Gao; Kenneth A Jacobson
Journal:  Mol Pharmacol       Date:  2017-09-01       Impact factor: 4.436

Review 7.  The emerging roles of β-arrestins in fibrotic diseases.

Authors:  Yuan-jing Gu; Wu-yi Sun; Sen Zhang; Jing-jing Wu; Wei Wei
Journal:  Acta Pharmacol Sin       Date:  2015-09-21       Impact factor: 6.150

Review 8.  MC1R, the cAMP pathway, and the response to solar UV: extending the horizon beyond pigmentation.

Authors:  Jose C García-Borrón; Zalfa Abdel-Malek; Celia Jiménez-Cervantes
Journal:  Pigment Cell Melanoma Res       Date:  2014-05-30       Impact factor: 4.693

9.  Conformation of receptor-bound visual arrestin.

Authors:  Miyeon Kim; Sergey A Vishnivetskiy; Ned Van Eps; Nathan S Alexander; Whitney M Cleghorn; Xuanzhi Zhan; Susan M Hanson; Takefumi Morizumi; Oliver P Ernst; Jens Meiler; Vsevolod V Gurevich; Wayne L Hubbell
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-22       Impact factor: 11.205

10.  On the selectivity of the Gαq inhibitor UBO-QIC: A comparison with the Gαi inhibitor pertussis toxin.

Authors:  Zhan-Guo Gao; Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2016-03-05       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.